- Insider Monkey•9 hours ago
Peter Kolchinsky‘s RA Capital Management has slashed its position in Alcobra Ltd (NASDAQ:ADHD) to just under 1.31 million shares according to a new 13G filing with the SEC. The position now amounts to 4.7% of the stock’s float and is well down from the more than 3.03 million Alcobra shares which RA Capital owned as of June […]
- GlobeNewswire•17 days ago
TEL AVIV, Israel, Oct. 07, 2016-- Alcobra Ltd., an emerging pharmaceutical company focused on the development of new medications to treat patients with cognitive disorders, including Attention Deficit ...
- 24/7 Wall St.•22 days ago
There are some companies hitting lows and creating huge shareholder losses while the market is just below all-time highs. These are the same companies holding back the market and destroying shareholders....
Alcobra Ltd. (ADHD)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
|Day's Range||2.28 - 2.37|
|52wk Range||1.95 - 8.78|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-2.89|
|Avg Vol (3m)||320,346|
|Dividend & Yield||N/A (N/A)|